<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T16:15:32Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/61877" metadataPrefix="edm">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/61877</identifier><datestamp>2024-12-16T07:27:16Z</datestamp><setSpec>com_10324_1133</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1209</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO rdf:about="https://uvadoc.uva.es/handle/10324/61877">
<dc:creator>Gutiérrez Abejón, Eduardo</dc:creator>
<dc:creator>Herrera Gómez, Francisco Magno</dc:creator>
<dc:creator>Pedrosa Naudín, M. Aránzazu</dc:creator>
<dc:creator>Tamayo Gómez, Eduardo</dc:creator>
<dc:creator>Álvarez González, Francisco Javier</dc:creator>
<dc:date>2022</dc:date>
<dc:description>Producción Científica</dc:description>
<dc:description>Background and Objectives: One of the most serious clinical outcomes in hospitalized patients with COVID-19 is severe acute respiratory syndrome (SARS). The aim is to analyze pharmacological treatment, survival and the main mortality predictors. Materials and Methods: A real-world data study from COVID-19-hospitalized patients with SARS from 1 March to 31 May 2020 has been carried out. Variables such as hospital length of stay, ventilation type and clinical outcomes have been taken into account. Results: In Castile and Leon, 14.03% of the 7307 in-hospital COVID-19 patients developed SARS, with a mortality rate of 42.53%. SARS prevalence was doubled in males compared to females, and 78.54% had an age of 65 years or more. The most commonly used medicines were antibiotics (89.27%), antimalarials (68.1%) and corticosteroids (55.9%). Survival of patients developing SARS was lower compared to patients without this complication (12 vs. 13 days). The main death predictors were disseminated intravascular coagulation (DIC) (OR: 13.87) and age (>65 years) (OR: 7.35). Conclusions: Patients older than 65 years who develop DIC have a higher probability of hospital death. Tocilizumab and steroids have been linked to a lower incidence of hospital death, being the main treatment for COVID-19 hospitalized patients with SARS.</dc:description>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://uvadoc.uva.es/handle/10324/61877</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>MDPI</dc:publisher>
<dc:subject>SARS-CoV-2</dc:subject>
<dc:subject>COVID-19</dc:subject>
<dc:subject>SARS (Disease)</dc:subject>
<dc:subject>Syndromes</dc:subject>
<dc:subject>Clinical findings</dc:subject>
<dc:subject>Pharmacotherapy</dc:subject>
<dc:subject>Survival</dc:subject>
<dc:subject>Supervivencia</dc:subject>
<dc:subject>Virology</dc:subject>
<dc:subject>3209 Farmacología</dc:subject>
<dc:subject>32 Ciencias Médicas</dc:subject>
<dc:subject>2420 Virología</dc:subject>
<dc:title>Hospitalized COVID-19 patients with severe acute respiratory syndrome: A population-based registry analysis to assess clinical findings, pharmacological treatment and survival</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation rdf:about="https://uvadoc.uva.es/handle/10324/61877#aggregation">
<edm:aggregatedCHO rdf:resource="https://uvadoc.uva.es/handle/10324/61877"/>
<edm:dataProvider>UVaDOC. Repositorio Documental de la Universidad de Valladolid</edm:dataProvider>
<edm:isShownAt rdf:resource="https://uvadoc.uva.es/handle/10324/61877"/>
<edm:isShownBy rdf:resource="https://uvadoc.uva.es/bitstream/10324/61877/1/Hospitalized-COVID-19-Patients.pdf"/>
<edm:provider>Hispana</edm:provider>
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</ore:Aggregation>
<edm:WebResource rdf:about="https://uvadoc.uva.es/bitstream/10324/61877/1/Hospitalized-COVID-19-Patients.pdf">
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</edm:WebResource>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>